Literature DB >> 11956063

Clinical findings and lung pathology in children with cystic fibrosis.

Refika Hamutcu1, Jon M Rowland, Monica V Horn, Cornelia Kaminsky, Eithne F MacLaughlin, Vaughn A Starnes, Marlyn S Woo.   

Abstract

Cystic fibrosis pulmonary disease is assessed by pulmonary function tests, arterial blood gases, and chest X-rays, but the correlation with lung pathology is unknown. We reviewed the clinical findings and lung pathology of 21 cystic fibrosis patients who had lung transplant. Pulmonary function tests, Brasfield scores, arterial blood gases, and age were correlated with lung pathology. All patients had severe Brasfield scores (9.0 +/- 3.2), airways obstruction (FEV1 25.6 +/- 5.6% predicted, FEF(25-75%) 11.0 +/- 4.5% predicted), and hyperinflation (residual volume [RV] 341.8 +/- 75.8% predicted). All patients were hypoxemic (PO2 64.2 +/- 8.2 mm Hg), and 5 of 21 (24%) were hypercapneic (PCO2 > 50 mm Hg). Pulmonary function tests and Brasfield scores were within a narrow range, and did not allow correlation with lung pathology. Small airway density (airways < 2 mm/cm2) decreased with increasing age. There were no differences in small airways inflammation and fibrous narrowing between the hypercapneic and nonhypercapneic patients, but the percent of smallest airways (airways < 0.35 mm) was significantly lower in the hypercapneic group. We conclude that there is significant correlation between airway pathology and increased age and CO2 retention. We speculate that decreased small airway density in older patients and the decreased proportion of smallest airways in hypercapneic patients is caused by increased dilatation of small airways.

Entities:  

Mesh:

Year:  2002        PMID: 11956063     DOI: 10.1164/ajrccm.165.8.2104090

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

Review 1.  Fungal Pathogens in CF Airways: Leave or Treat?

Authors:  A Singh; A Ralhan; C Schwarz; D Hartl; A Hector
Journal:  Mycopathologia       Date:  2017-08-02       Impact factor: 2.574

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Alveolar inflammation in cystic fibrosis.

Authors:  Martina Ulrich; Dieter Worlitzsch; Simona Viglio; Nanna Siegmann; Paolo Iadarola; Janis K Shute; Marianne Geiser; Gerald B Pier; Godehard Friedel; Mark L Barr; Antje Schuster; Keith C Meyer; Felix Ratjen; Thomas Bjarnsholt; Erich Gulbins; Gerd Döring
Journal:  J Cyst Fibros       Date:  2010-03-29       Impact factor: 5.482

4.  Higher Plasma Endothelial Markers in Adults with Cystic Fibrosis Compared with Healthy Age-matched Control Subjects.

Authors:  Pavan K Bhatraju; Katie B Hisert; Moira L Aitken; Christopher H Goss; W Conrad Liles; William A Altemeier
Journal:  Ann Am Thorac Soc       Date:  2019-06

5.  Intranasal micro-optical coherence tomography imaging for cystic fibrosis studies.

Authors:  Hui Min Leung; Susan E Birket; Chulho Hyun; Timothy N Ford; Dongyao Cui; George M Solomon; Ren-Jay Shei; Adegboyega Timothy Adewale; Andrew R Lenzie; Courtney M Fernandez-Petty; Hui Zheng; Justin H Palermo; Do-Yeon Cho; Bradford A Woodworth; Lael M Yonker; Bryan P Hurley; Steven M Rowe; Guillermo J Tearney
Journal:  Sci Transl Med       Date:  2019-08-07       Impact factor: 17.956

6.  Ets homologous factor (EHF) has critical roles in epithelial dysfunction in airway disease.

Authors:  Sara L Fossum; Michael J Mutolo; Antonio Tugores; Sujana Ghosh; Scott H Randell; Lisa C Jones; Shih-Hsing Leir; Ann Harris
Journal:  J Biol Chem       Date:  2017-05-01       Impact factor: 5.157

Review 7.  Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments.

Authors:  Louise Lannefors; Brenda M Button; Maggie McIlwaine
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

8.  Constrictive Bronchiolitis in Cystic Fibrosis Adolescents with Refractory Pulmonary Decline.

Authors:  William T Harris; J Todd Boyd; Gary L McPhail; Alan S Brody; Rhonda D Szczesniak; Leslie L Korbee; Michael L Baker; John P Clancy
Journal:  Ann Am Thorac Soc       Date:  2016-12

Review 9.  Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis.

Authors:  William McKleroy; Ting-Hein Lee; Kamran Atabai
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-05       Impact factor: 5.464

10.  Kidney and Liver Injuries After Major Burns in Rats Are Prevented by Resolvin D2.

Authors:  Yoshitaka Inoue; Yong-Ming Yu; Tomohiro Kurihara; Aleksandr Vasilyev; Amir Ibrahim; Rahmi Oklu; Gaofeng Zhao; Anil V Nair; Dennis Brown; Alan J Fischman; Ronald G Tompkins; Daniel Irimia
Journal:  Crit Care Med       Date:  2016-05       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.